Search

Your search keyword '"Oshinaike,Olajumoke"' showing total 151 results

Search Constraints

Start Over You searched for: Author "Oshinaike,Olajumoke" Remove constraint Author: "Oshinaike,Olajumoke"
151 results on '"Oshinaike,Olajumoke"'

Search Results

1. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study

2. APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s disease

3. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study

4. A protocol for the study of environmental risk factors and candidate gene–environment interactions in neurodegenerative disorders in Nigeria (SERGEND): A cross-sectional descriptive study.

5. MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset

7. Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson’s Disease in African and African Admixed Populations

8. APOE E4 is associated with cognitive decline but not with disease risk or age of onset in Nigerians with Parkinson’s disease

11. A Cross‐Sectional Comprehensive Assessment of the Profile and Burden of Non‐motor Symptoms in Relation to Motor Phenotype in the Nigeria Parkinson Disease Registry Cohort

12. Mean platelet volume and platelet counts in type 2 Diabetes: Mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria

15. Early-Onset Parkinson Disease Screening in Patients From Nigeria

18. The Nigeria Parkinson Disease Registry: Process, Profile, and Prospects of a Collaborative Project

19. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders

20. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders

21. Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria

22. Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti-HBcore and IgM anti-HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria

23. Predicting outcome in traumatic brain injury using a new outcome assessment scale – The Lagos Brain Disability Examination Scale (LABDES)

26. Clinical profile of parkinsonism and Parkinson's disease in Lagos, Southwestern Nigeria

27. Predicting outcome in traumatic brain injury using a new outcome assessment scale – The Lagos Brain Disability Examination Scale (LABDES).

31. New-Onset Seizures in HIV Patients on Antiretroviral Therapy at a Tertiary Centre in South-West, Nigeria

32. A Nationwide Survey of Parkinson's Disease Medicines Availability and Affordability in Nigeria.

33. Mean platelet volume and platelet counts in type 2 Diabetes: Mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria

34. Steady state hemoglobin concentration and packed cell volume in homozygous sickle cell disease patients in Lagos, Nigeria

35. Seroprevalence of human T-lymphotropic virus antibodies among patients with lymphoid malignancies at a tertiary center in Lagos, Nigeria

36. The relationship between red blood cell distribution width and blood pressure in patients with type 2 diabetes mellitus in Lagos, Nigeria

37. The relationship between red blood cell distribution width and blood pressure in patients with type 2 diabetes mellitus in Lagos, Nigeria

45. Serum ferritin levels in adults with sickle cell disease in Lagos, Nigeria

Catalog

Books, media, physical & digital resources